These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9636517)

  • 1. Specificity of therapeutic drug monitoring of tacrolimus in kidney transplant patients.
    Sato S; Fuchinoue S; Tojimbara T; Fujita S; Nakajima I; Agishi T; Hayashi T; Teramura Y; Fujita E; Iwasaki K
    Transplant Proc; 1998 Jun; 30(4):1274-5. PubMed ID: 9636517
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical relevance of monitoring tacrolimus: comparison of microparticle enzyme immunoassay, enzyme-linked immunosorbent assay, and liquid chromatography mass spectrometry in renal transplant recipients converted from cyclosporine to tacrolimus.
    Braun F; Lorf T; Schütz E; Christians U; Grupp C; Sattler B; Canelo R; Sewing KF; Armstrong VW; Oellerich M; Ringe B
    Transplant Proc; 1996 Dec; 28(6):3175-6. PubMed ID: 8962231
    [No Abstract]   [Full Text] [Related]  

  • 3. Usefulness of monitoring of AUC(0-4h) during the induction period of immunosuppressive therapy with tacrolimus after renal transplantation.
    Uchida K; Tominaga Y; Haba T; Katayama T; Matsuoka S; Sato T; Goto N; Takeda A; Morozumi K; Takagi H
    Transplant Proc; 2002 Aug; 34(5):1736-7. PubMed ID: 12176556
    [No Abstract]   [Full Text] [Related]  

  • 4. The roles of C4 and AUC0-4 in monitoring of tacrolimus in stable kidney transplant patients.
    Pisitkun T; Eiam-Ong S; Chusil S; Praditpornsilpa K; Pansin P; Tungsanga K
    Transplant Proc; 2002 Dec; 34(8):3173-5. PubMed ID: 12493410
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic drug monitoring of cyclosporine and tacrolimus. Update on Lake Louise Consensus Conference on cyclosporin and tacrolimus.
    Oellerich M; Armstrong VW; Schütz E; Shaw LM
    Clin Biochem; 1998 Jul; 31(5):309-16. PubMed ID: 9721427
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of factors influencing tacrolimus levels and immunoassay bias in renal transplantation.
    Borrows R; Chusney G; Loucaidou M; James A; Goel S; Borrows S; Van Tromp J; Cairns T; Griffith M; Hakim N; McLean A; Palmer A; Papalois V; Taube D
    J Clin Pharmacol; 2007 Aug; 47(8):1035-42. PubMed ID: 17660485
    [No Abstract]   [Full Text] [Related]  

  • 7. Pitfalls in monitoring tacrolimus (FK 506).
    Braun F; Schütz E; Christians U; Lorf T; Schiffmann JH; Armstrong VW; Schröter W; Sewing KF; Oellerich M; Ringe B
    Ther Drug Monit; 1997 Dec; 19(6):628-31. PubMed ID: 9421102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting the pharmacokinetics of tacrolimus in the first year after renal transplantation. European Tacrolimus Multicentre Renal Study Group.
    Undre NA; Schäfer A
    Transplant Proc; 1998 Jun; 30(4):1261-3. PubMed ID: 9636512
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of the new EMIT enzyme immunoassay for the determination of whole-blood tacrolimus concentrations in kidney, heart, and liver transplant recipients.
    Hesse CJ; Baan CC; Balk AH; Metselaar HJ; Weimar W; van Gelder T
    Transplant Proc; 2002 Nov; 34(7):2988-90. PubMed ID: 12431679
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetics, dosing principles, and blood level monitoring of FK506.
    Sewing KF
    Transplant Proc; 1994 Dec; 26(6):3267-9. PubMed ID: 7527962
    [No Abstract]   [Full Text] [Related]  

  • 11. Defining the initial doses of sirolimus and tacrolimus in the period immediately after renal transplantation.
    Jiménez O; Campistol JM; Vidal E; Faura A; Oppenheimer F; Corbella J; Brunet M
    Transplant Proc; 2003 Aug; 35(5):1686-8. PubMed ID: 12962758
    [No Abstract]   [Full Text] [Related]  

  • 12. Pretransplant pharmacokinetics: does it predict the dose of tacrolimus after renal transplantation?
    Boots JM; Christiaans MH; Undre NA; van Hooff JP
    Transplant Proc; 2002 Dec; 34(8):3171-2. PubMed ID: 12493409
    [No Abstract]   [Full Text] [Related]  

  • 13. Is microparticle enzyme-linked immunoassay (MEIA) reliable for use in tacrolimus TDM? Comparison of MEIA to liquid chromatography with mass spectrometric detection using longitudinal trough samples from transplant recipients.
    Napoli KL
    Ther Drug Monit; 2006 Aug; 28(4):491-504. PubMed ID: 16885716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic monitoring of tacrolimus in pediatric and adult transplanted patients.
    Capone D; Gentile A; Vajro P; Stanziale P; Imperatore P; De Silva C; Pellegrino T; Basile V
    J Chemother; 1998 Apr; 10(2):176-8. PubMed ID: 9603651
    [No Abstract]   [Full Text] [Related]  

  • 15. Tacrolimus dosing requirements in diabetic and nondiabetic patients calculated from pretransplantation data.
    van Duijnhoven E; Christiaans M; Schäfer A; Undre N; van Hooff J
    Transplant Proc; 1998 Jun; 30(4):1266-7. PubMed ID: 9636514
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics of tacrolimus in paediatric renal transplant recipients.
    Webb NJ; Stevenson PJ; Lewis MA; Postlethwaite RJ; Bradbury MG; Undre N
    Transplant Proc; 2002 Aug; 34(5):1948-50. PubMed ID: 12176639
    [No Abstract]   [Full Text] [Related]  

  • 17. Alterations in calcineurin phosphatase activity in tacrolimus-treated renal transplant patients.
    Koefoed-Nielsen PB; Jørgensen KA
    Transplant Proc; 2002 Aug; 34(5):1743-4. PubMed ID: 12176559
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical influencing factors for daily dose, trough level, and relative clearance of tacrolimus in renal transplant recipients.
    Hu RH; Lee PH; Tsai MK
    Transplant Proc; 2000 Nov; 32(7):1689-92. PubMed ID: 11119894
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of tacrolimus primary immunosuppression in kidney transplant recipients.
    Braun F; Schütz E; Peters B; Talaulicar R; Grupp C; Undre N; Schäfer A; Armstrong VW; Oellerich M; Ringe B
    Transplant Proc; 2001 May; 33(3):2127-8. PubMed ID: 11377473
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic drug monitoring of tacrolimus in kidney transplantation: 9-month follow-up.
    Brunet M; Torregrosa JV; Oppenheimer F; Corbella J
    Transplant Proc; 1998 Dec; 30(8):4068-9. PubMed ID: 9865298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.